MWM
ABMD

Meridian Wealth Management’s Abiomed Inc ABMD Stock Holding History

Meridian Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-215
Closed -$560 – 535
2019
Q2 		$560 Buy
+215
New +$57K 0.02% 361
2018
Q4 		– Sell
-715
Closed -$322K – 201
2018
Q3 		$322K Buy
715
+190
+36% +$74.9K 0.14% 128
2018
Q2 		$215K Buy
+525
New +$190K 0.1% 169

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Meridian Wealth Management's ABMD Position: Q3 2019 in Review

Meridian Wealth Management sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 215 shares — an estimated $560 sold.

Meridian Wealth Management first reported a position in ABMD in Q2 2018 and held it in 3 quarters. The position peaked at $322K in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Meridian Wealth Management reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Meridian Wealth Management sold 215 Abiomed Inc shares in Q3 2019, an estimated $560.
  • Meridian Wealth Management first reported a position in Abiomed Inc in Q2 2018 and held it in 3 quarters.
  • Meridian Wealth Management's Abiomed Inc position peaked at $322K in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Meridian Wealth Management's 13F filing for Q3 2019, filed 8 Nov 2019.